Vanda Pharmaceuticals Inc.

Issuer

Vanda Pharmaceuticals Inc.

Principal executive office address

2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037

Citizenship

Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States

Filing person

Millennium Management LLC Millennium Group Management LLC Israel A. Englander

Principal business or residence address

Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022

Not applicable indication

Y

Percent of class

See response to Item 11 on each cover page.

Amount beneficially owned

See response to Item 9 on each cover page.

Sole voting power

See response to Item 5 on each cover page.

Shared voting power

See response to Item 6 on each cover page.

Sole dispositive power

See response to Item 7 on each cover page.

Shared dispositive power

See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Not applicable indication

Y

Not applicable indication

Y

Not applicable indication

Y

Not applicable indication

Y

Not applicable indication

Y

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Exhibit I: Joint Filing Agreement, dated as of October 8, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.